NTRK1 and Autoimmunity: Although there have been no case reports to date of cutaneous lupus induced by erdafitinib, few case reports have reported inhibition of other receptor tyrosine kinases in triggering autoimmunity.8, 9, 10 The mechanism is not clearly understood, although may be related to aberrant inflammation after cell death induced by these therapies.8